{"id":"ceftriaxone-intravenous","safety":{"commonSideEffects":[{"rate":"2-3%","effect":"Diarrhea"},{"rate":"1-2%","effect":"Rash"},{"rate":"1-2%","effect":"Phlebitis at injection site"},{"rate":"1%","effect":"Nausea"},{"rate":"1-3%","effect":"Hypersensitivity reactions"}]},"_chembl":null,"_fixedAt":"2026-03-30T13:41:40.301249","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ceftriaxone is a third-generation cephalosporin antibiotic that penetrates bacterial cell walls and irreversibly binds to penicillin-binding proteins, preventing the cross-linking of peptidoglycan strands. This disrupts cell wall integrity, leading to bacterial cell lysis and death. It has broad-spectrum activity against gram-positive and gram-negative bacteria, with particularly strong activity against aerobic gram-negative organisms.","oneSentence":"Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking cross-linking of peptidoglycan.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:05:14.084Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections (meningitis, pneumonia, gonorrhea, Lyme disease, sepsis)"},{"name":"Surgical prophylaxis"}]},"_fixedFields":["pubmed(2061)"],"trialDetails":[{"nctId":"NCT07207876","phase":"","title":"Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy","status":"RECRUITING","sponsor":"International Maternal Pediatric Adolescent AIDS Clinical Trials Group","startDate":"2026-02-16","conditions":"Pregnancy","enrollment":110},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT06080698","phase":"NA","title":"Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-02-22","conditions":"Gram-negative Bacteremia","enrollment":1030},{"nctId":"NCT06494072","phase":"PHASE4","title":"Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-08-22","conditions":"Community Acquired Pneumonia in Children","enrollment":236},{"nctId":"NCT06819592","phase":"PHASE3","title":"PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury","status":"RECRUITING","sponsor":"The George Institute","startDate":"2025-10-30","conditions":"All-cause Mortality, Quality of Life, Disability, Intellectual","enrollment":3300},{"nctId":"NCT06437964","phase":"NA","title":"Prophylactic Antibiotics in Endoscopic Secondary Prevention of Gastroesophageal Variceal Bleeding","status":"ACTIVE_NOT_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-05-25","conditions":"Cirrhosis, Liver, Hypertension, Portal, Variceal Hemorrhage","enrollment":226},{"nctId":"NCT05544565","phase":"PHASE4","title":"3-day IV Antibiotic Treatment Versus 3-day IV Followed by 7-day Oral Antibiotic Treatment for AP in Children","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-03-22","conditions":"Pyelonephritis Acute","enrollment":480},{"nctId":"NCT07308457","phase":"NA","title":"Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients","status":"RECRUITING","sponsor":"Pomeranian Medical University Szczecin","startDate":"2024-09-01","conditions":"Incidence of Infectious Diseases","enrollment":100},{"nctId":"NCT03895567","phase":"PHASE1","title":"Study to Compare Blood Levels of Ceftriaxone Given by Suppository or Injection.","status":"SUSPENDED","sponsor":"University of Oxford","startDate":"2026-12","conditions":"Healthy","enrollment":37},{"nctId":"NCT07236944","phase":"PHASE4","title":"Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care","status":"RECRUITING","sponsor":"Uppsala University","startDate":"2025-12","conditions":"Febrile Urinary Tract Infection","enrollment":560},{"nctId":"NCT03413384","phase":"PHASE2","title":"To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia","status":"ACTIVE_NOT_RECRUITING","sponsor":"BrainX Corporation","startDate":"2019-02-15","conditions":"Parkinson's Disease Dementia","enrollment":100},{"nctId":"NCT03068741","phase":"PHASE4","title":"Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Damon Scales","startDate":"2020-03-23","conditions":"Severe Sepsis or Septic Shock","enrollment":2040},{"nctId":"NCT05121974","phase":"PHASE2","title":"Tebipenem Trial in Children With Shigellosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2022-08-18","conditions":"Shigellosis","enrollment":132},{"nctId":"NCT02996656","phase":"NA","title":"Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery","status":"RECRUITING","sponsor":"Université de Montréal","startDate":"2016-12","conditions":"Propionibacterium Infection","enrollment":88},{"nctId":"NCT06423898","phase":"PHASE4","title":"Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.","status":"RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2024-10-09","conditions":"Endocarditis, Infective","enrollment":284},{"nctId":"NCT04975945","phase":"PHASE4","title":"Assessing Parenteral Antibiotics Versus Single-time Intra-operative Intra-dermal Antibiotic Administration for Prevention of SSI","status":"WITHDRAWN","sponsor":"The Grant Medical College & Sir J.J. Group of Hospitals","startDate":"2021-08","conditions":"Surgical Wound Infection, Surgical Site Infection","enrollment":""},{"nctId":"NCT05470517","phase":"PHASE2","title":"Antibiotic Instillation in Appendicitis","status":"COMPLETED","sponsor":"Johns Hopkins All Children's Hospital","startDate":"2023-01-05","conditions":"Complicated Appendicitis, Acute Appendicitis","enrollment":190},{"nctId":"NCT05929599","phase":"NA","title":"Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Children's Hospital, Vietnam","startDate":"2023-07-05","conditions":"Acute Respiratory Tract Infections, Pneumonia, Respiratory Syncytial Virus (RSV)","enrollment":120},{"nctId":"NCT06166381","phase":"NA","title":"Parenteral Versus Combined Parenteral With Vancomycin-soaked Graft in ACL Reconstruction","status":"RECRUITING","sponsor":"University of Duhok","startDate":"2024-01-25","conditions":"Infection, Bacterial","enrollment":288},{"nctId":"NCT05849090","phase":"EARLY_PHASE1","title":"Vancomycin and Tobramycin Powder Use in Acute Open Fractures","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-03-27","conditions":"Infections","enrollment":10},{"nctId":"NCT05899140","phase":"PHASE4","title":"Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial","status":"RECRUITING","sponsor":"Frieder Schaumburg","startDate":"2024-03-15","conditions":"Skin Infection, Staphylococcal Infections, Staphylococcus Aureus Infection","enrollment":100},{"nctId":"NCT06532409","phase":"NA","title":"Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone","status":"NOT_YET_RECRUITING","sponsor":"RESnTEC, Institute of Research","startDate":"2024-10-01","conditions":"Community-acquired Pneumonia","enrollment":114},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04041791","phase":"PHASE3","title":"A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-08-19","conditions":"Pneumonia","enrollment":4392},{"nctId":"NCT03681431","phase":"PHASE2","title":"Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2018-04-23","conditions":"Infectious Endocarditis","enrollment":12},{"nctId":"NCT05925140","phase":"PHASE1","title":"LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients","status":"UNKNOWN","sponsor":"Lebanese University","startDate":"2020-03-28","conditions":"COVID-19, Hospitalized COVID-19 Patients","enrollment":1000},{"nctId":"NCT06220929","phase":"PHASE4","title":"Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury","status":"UNKNOWN","sponsor":"Sichuan Provincial People's Hospital","startDate":"2024-01-15","conditions":"Sepsis, Liver Dysfunction","enrollment":40},{"nctId":"NCT04724044","phase":"PHASE3","title":"Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2021-01-25","conditions":"Community-acquired Pneumonia, Sepsis, Inflammatory Response","enrollment":278},{"nctId":"NCT05156437","phase":"PHASE4","title":"Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)","status":"ENROLLING_BY_INVITATION","sponsor":"Vinay Badhwar","startDate":"2022-03-16","conditions":"Endocarditis","enrollment":20},{"nctId":"NCT05199324","phase":"PHASE4","title":"Early Oral Step-down Antibiotic Therapy for Uncomplicated Gram-negative Bacteraemia","status":"UNKNOWN","sponsor":"Tan Tock Seng Hospital","startDate":"2022-04-01","conditions":"Gram-negative Bacteraemia","enrollment":720},{"nctId":"NCT03179384","phase":"PHASE4","title":"Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2017-06-26","conditions":"Pyelonephritis Acute","enrollment":9},{"nctId":"NCT05624229","phase":"PHASE4","title":"Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2023-10-01","conditions":"Upper Gastrointestinal Hemorrhage","enrollment":672},{"nctId":"NCT05149287","phase":"PHASE2","title":"PROPER Trial of Pain and Inflammation After Knee Arthroscopy","status":"TERMINATED","sponsor":"Austin V Stone","startDate":"2021-12-28","conditions":"Meniscus Tear, Meniscus Lesion, Cartilage Injury","enrollment":5},{"nctId":"NCT02389036","phase":"PHASE3","title":"Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients","status":"COMPLETED","sponsor":"The George Institute","startDate":"2017-05-01","conditions":"Critical Illness, Sepsis, Septic Shock","enrollment":20010},{"nctId":"NCT05293132","phase":"PHASE2, PHASE3","title":"Effect of Montelukast Versus Co Enzyme in Sepsis","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-02-01","conditions":"Sepsis","enrollment":90},{"nctId":"NCT05398081","phase":"PHASE2","title":"Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery","status":"COMPLETED","sponsor":"Dr. Promise Tamunoipiriala Jaja","startDate":"2021-12-01","conditions":"Surgical Site Infection, Antibiotics Prophylaxis","enrollment":96},{"nctId":"NCT03439124","phase":"PHASE3","title":"Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia","status":"COMPLETED","sponsor":"Basilea Pharmaceutica","startDate":"2017-11-27","conditions":"Community-acquired Pneumonia (CAP), Hospital-acquired Pneumonia (HAP)","enrollment":138},{"nctId":"NCT00138801","phase":"PHASE3","title":"Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis","status":"COMPLETED","sponsor":"Sorlandet Hospital HF","startDate":"2004-03","conditions":"Lyme Neuroborreliosis","enrollment":120},{"nctId":"NCT03087656","phase":"PHASE4","title":"Antibiotics to Decrease Post ERCP Cholangitis","status":"UNKNOWN","sponsor":"University of Southern California","startDate":"2017-03-29","conditions":"Cholangitis","enrollment":200},{"nctId":"NCT04218695","phase":"PHASE4","title":"Prophylactic Antibiotics in Admitted Cirrhotics","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2020-08-24","conditions":"Cirrhosis, Liver","enrollment":32},{"nctId":"NCT05654896","phase":"PHASE3","title":"Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Nadeem Iqbal","startDate":"2022-11-26","conditions":"Antibiotic Prophylaxis","enrollment":158},{"nctId":"NCT02334124","phase":"NA","title":"Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2015-01","conditions":"Cellulitis","enrollment":190},{"nctId":"NCT05535725","phase":"PHASE4","title":"Application of Powdered Vancomycin in the Surgical Wound in Haiti","status":"COMPLETED","sponsor":"Clinique Ortos","startDate":"2019-10-10","conditions":"Surgical Site Infection","enrollment":230},{"nctId":"NCT04935515","phase":"NA","title":"C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.","status":"COMPLETED","sponsor":"Manimarane Arjunan, MD,DM (Cardiology)","startDate":"2021-04-15","conditions":"COVID -19","enrollment":25},{"nctId":"NCT04839653","phase":"NA","title":"Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria","status":"UNKNOWN","sponsor":"MEDSI Clinical Hospital 1, ICU","startDate":"2021-05-01","conditions":"Pneumonia, Ventilator-Associated, Pneumonia, Bloodstream Infection","enrollment":60},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT00462020","phase":"NA","title":"Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2007-03","conditions":"Perforated Appendicitis","enrollment":102},{"nctId":"NCT03583749","phase":"","title":"Pharmacokinetics and Safety of Antimicrobial Agents Administered by Subcutaneous Route in Patients AGEd Over 65 Years","status":"UNKNOWN","sponsor":"University Hospital, Bordeaux","startDate":"2019-08-07","conditions":"Antimicrobials, Subcutaneous Injection, Antibiotic","enrollment":150},{"nctId":"NCT00161330","phase":"PHASE3","title":"Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT","status":"TERMINATED","sponsor":"University of Padova","startDate":"2000-06","conditions":"Urinary Tract Infections","enrollment":440},{"nctId":"NCT03794765","phase":"PHASE2","title":"Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-04-01","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases, Acute Severe Colitis","enrollment":50},{"nctId":"NCT03080103","phase":"","title":"Appendectomy Versus Conservative Treatment for Uncomplicated Acute Appendicitis","status":"COMPLETED","sponsor":"Mauro Podda","startDate":"2017-06-01","conditions":"Acute Appendicitis, Appendicitis Recurrent, Appendectomy","enrollment":300},{"nctId":"NCT04141787","phase":"PHASE4","title":"Ceftriaxone as Home IV for Staph Infections","status":"UNKNOWN","sponsor":"Vancouver Island Health Authority","startDate":"2019-07-11","conditions":"Staphylococcal Infections, Osteomyelitis, CNS Infection","enrollment":310},{"nctId":"NCT03477422","phase":"PHASE3","title":"CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria","status":"COMPLETED","sponsor":"Venus Remedies Limited","startDate":"2014-01-11","conditions":"Urinary Tract Infection Complicated, Acute Pyelonephritis","enrollment":230},{"nctId":"NCT02142751","phase":"PHASE3","title":"Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2014-07","conditions":"Infection Due to ESBL Escherichia Coli","enrollment":161},{"nctId":"NCT01635530","phase":"PHASE4","title":"Study of Lyme Neuroborreliosis","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2012-08","conditions":"Lyme Neuroborreliosis","enrollment":210},{"nctId":"NCT02605122","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia","status":"TERMINATED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2016-04","conditions":"Community-acquired Bacterial Pneumonia","enrollment":97},{"nctId":"NCT02419001","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy","status":"COMPLETED","sponsor":"Theriva Biologics, Inc.","startDate":"2015-03","conditions":"Healthy Volunteers","enrollment":11},{"nctId":"NCT03665376","phase":"NA","title":"Feasibility and Efficacy of Enhanced Recovery After Surgery (ERAS) on Length of Stay Among Laparotomy Patients at Mbarara Regional Referral Hospital","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2017-06-01","conditions":"Laparotomy","enrollment":33},{"nctId":"NCT01723150","phase":"PHASE4","title":"Antibiotics for Klebsiella Liver Abscess Study","status":"COMPLETED","sponsor":"National University Hospital, Singapore","startDate":"2013-11-05","conditions":"Liver Abscess, Pyogenic","enrollment":152},{"nctId":"NCT03518463","phase":"NA","title":"Enhanced Recovery After Surgery for Emergency Caesarean Deliveries","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2017-06-20","conditions":"Pregnancy Related","enrollment":160},{"nctId":"NCT02328469","phase":"","title":"Aseptic Meningoencephalitis in Slovenia","status":"UNKNOWN","sponsor":"University Medical Centre Ljubljana","startDate":"2014-06","conditions":"Aseptic Meningitis","enrollment":800},{"nctId":"NCT01371838","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-12","conditions":"Community-Acquired Bacterial Pneumonia, Lung Infection of Individual Not Recently Hospitalized","enrollment":848},{"nctId":"NCT02561442","phase":"PHASE2, PHASE3","title":"Crossover Study to Compare the Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone Administration","status":"COMPLETED","sponsor":"scPharmaceuticals, Inc.","startDate":"2015-10","conditions":"Pharmacokinetics in Healthy Adults","enrollment":18},{"nctId":"NCT00621504","phase":"PHASE3","title":"Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2008-01","conditions":"Bacterial Pneumonia","enrollment":606},{"nctId":"NCT00035347","phase":"PHASE4","title":"Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia","status":"COMPLETED","sponsor":"Pfizer","startDate":"2001-01","conditions":"Community-Acquired Pneumonia (CAP)","enrollment":219},{"nctId":"NCT01421693","phase":"PHASE4","title":"Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever","status":"COMPLETED","sponsor":"Oxford University Clinical Research Unit, Vietnam","startDate":"2011-09","conditions":"Enteric Fever, Typhoid Fever","enrollment":300},{"nctId":"NCT01207739","phase":"PHASE4","title":"Persistent Lyme Empiric Antibiotic Study Europe","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2010-09","conditions":"Lyme Disease, Borrelia Infection","enrollment":280},{"nctId":"NCT02742948","phase":"PHASE2","title":"The Optimal Time for Intravenous Antibiotic Prophylaxis in Elective Cesarean Section","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2016-04","conditions":"Endometritis","enrollment":600},{"nctId":"NCT00797108","phase":"PHASE2","title":"A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-01","conditions":"Pneumonia, Bacterial","enrollment":35},{"nctId":"NCT02098486","phase":"PHASE2","title":"Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP","status":"COMPLETED","sponsor":"Kangbuk Samsung Hospital","startDate":"2014-03","conditions":"Cholangitis","enrollment":86},{"nctId":"NCT01645735","phase":"PHASE4","title":"Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2012-10","conditions":"Infections","enrollment":49},{"nctId":"NCT00838864","phase":"PHASE4","title":"Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding","status":"COMPLETED","sponsor":"Far Eastern Memorial Hospital","startDate":"2009-03","conditions":"Esophageal and Gastric Varices, Gastrointestinal Hemorrhage","enrollment":79},{"nctId":"NCT02177994","phase":"PHASE3","title":"Antibiotic Prophylaxis for Elective Cesarean Section","status":"COMPLETED","sponsor":"Ain Shams Maternity Hospital","startDate":"2013-09","conditions":"Infection of Cesarian Section Wound Following Delivery","enrollment":328},{"nctId":"NCT00769171","phase":"PHASE3","title":"Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-10","conditions":"Infection, Intra-abdominal","enrollment":364},{"nctId":"NCT00431678","phase":"PHASE3","title":"Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-01","conditions":"Pneumonia","enrollment":738},{"nctId":"NCT02224040","phase":"PHASE4","title":"Typhoid Fever: Combined vs. Single Antibiotic Therapy","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2013-08","conditions":"Typhoid Fever","enrollment":120},{"nctId":"NCT01390623","phase":"PHASE4","title":"Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women","status":"COMPLETED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2011-07","conditions":"Acute Uncomplicated Pyelonephritis","enrollment":39},{"nctId":"NCT01473836","phase":"PHASE3","title":"A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-11","conditions":"Intra-abdominal Infections","enrollment":38},{"nctId":"NCT00493220","phase":"PHASE1","title":"Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2007-06","conditions":"Healthy","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2061,"recentPublications":[{"date":"2026 Feb 27","pmid":"41901709","title":"Ocular Syphilis in Individuals with and Without HIV: A Single-Center University Hospital Experience.","journal":"Pathogens (Basel, Switzerland)"},{"date":"2026 Mar 24","pmid":"41891471","title":"Borreliakarditt.","journal":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke"},{"date":"2026 Mar","pmid":"41853106","title":"Septic arthritis due to Corynebacterium propinquum: first report of isolation from synovial fluid in a native joint.","journal":"ASM case reports"},{"date":"2026 Mar 11","pmid":"41817257","title":"Adjuvant Cilostazol Therapy to Help Restore Atrioventricular Conduction in Lyme Carditis.","journal":"JACC. Case reports"},{"date":"2026","pmid":"41810360","title":"Prescription precision: Evaluating antimicrobial prescription practices in paediatric and neonatal inpatients.","journal":"Southern African journal of infectious diseases"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["generic name: ceftriaxone","Pharmaceutical form: solution for infusion","ATC code:J01DA"],"phase":"phase_3","status":"active","brandName":"Ceftriaxone intravenous","genericName":"Ceftriaxone intravenous","companyName":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","companyId":"fundaci-n-p-blica-andaluza-para-la-gesti-n-de-la-investigaci-n-en-sevilla","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking cross-linking of peptidoglycan. Used for Bacterial infections (meningitis, pneumonia, gonorrhea, Lyme disease, sepsis), Surgical prophylaxis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}